Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury

Joshua K. Wong; Günther Deuschl; Robin Wolke; Hagai Bergman; Muthuraman Muthuraman; Sergiu Groppa; Sameer A. Sheth; Helen M. Bronte-Stewart; Kevin B. Wilkins; Matthew N. Petrucci; Emilia Lambert; Yasmine Kehnemouyi; Philip A. Starr; Simon Little; Juan Anso; Ro’ee Gilron; Lawrence Poree; Giridhar P. Kalamangalam; Gregory A. Worrell; Kai J. Miller; Nicholas D. Schiff; Christopher R. Butson; Jaimie M. Henderson; Jack W. Judy; Adolfo Ramirez-Zamora; Kelly D. Foote; Peter A. Silburn; Luming Li; Genko Oyama; Hikaru Kamo; Satoko Sekimoto; Nobutaka Hattori; James J. Giordano; Diane DiEuliis; John R. Shook; Darin D. Doughtery; Alik S. Widge; Helen S. Mayberg; Jungho Cha; Kisueng Choi; Stephen Heisig; Mosadolu Obatusin; Enrico Opri; Scott B. Kaufman; Prasad Shirvalkar; Christopher J. Rozell; Sankaraleengam Alagapan; Robert S. Raike; Hemant Bokil; David Green; Michael S. Okun

doi:10.3389/fnhum.2022.813387

Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury

Joshua K. Wong, Günther Deuschl, Robin Wolke, Hagai Bergman, Muthuraman Muthuraman, Sergiu Groppa, Sameer A. Sheth, Helen M. Bronte-Stewart, Kevin B. Wilkins, Matthew N. Petrucci, Emilia Lambert, Yasmine Kehnemouyi, Philip A. Starr, Simon Little, Juan Anso, Ro’ee Gilron, Lawrence Poree, Giridhar P. Kalamangalam, Gregory A. Worrell, Kai J. MillerNicholas D. Schiff, Christopher R. Butson, Jaimie M. Henderson, Jack W. Judy, Adolfo Ramirez-Zamora, Kelly D. Foote, Peter A. Silburn, Luming Li, Genko Oyama, Hikaru Kamo, Satoko Sekimoto, Nobutaka Hattori, James J. Giordano, Diane DiEuliis, John R. Shook, Darin D. Doughtery, Alik S. Widge, Helen S. Mayberg, Jungho Cha, Kisueng Choi, Stephen Heisig, Mosadolu Obatusin, Enrico Opri, Scott B. Kaufman, Prasad Shirvalkar, Christopher J. Rozell, Sankaraleengam Alagapan, Robert S. Raike, Hemant Bokil, David Green, Michael S. Okun

Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

DBS Think Tank IX was held on August 25–27, 2021 in Orlando FL with US based participants largely in person and overseas participants joining by video conferencing technology. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging deep brain stimulation (DBS) technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank IX speakers was that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. After collectively sharing our experiences, it was estimated that globally more than 230,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. As such, this year’s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia and Australia; cutting-edge technologies, neuroethics, interventional psychiatry, adaptive DBS, neuromodulation for pain, network neuromodulation for epilepsy and neuromodulation for traumatic brain injury.

Original language	English (US)
Article number	813387
Journal	Frontiers in Human Neuroscience
Volume	16
DOIs	https://doi.org/10.3389/fnhum.2022.813387
State	Published - Mar 4 2022

Bibliographical note

Funding Information:
JW’s research was supported by NIH R25NS108939. SAS was a consultant for Boston Scientific, Abbott, Zimmer Biomet, and Neuropace. SAS was also funded by NIH UH3 NS103549, the McNair Foundation, and the Dana Foundation. HB-S served on the Clinical Advisory Board for Medtronic. PAS received research support and fellowship training support from Medtronic. NS was a member of the scientific advisory board for EnspireDBS, Inc. and QuantalX, Inc. NS also received current grant funding from the BRAIN Initiative, National Institute of Neurological Disorders and Stroke, and the James S. McDonnell Foundation. CB holds intellectual property related to some of the results presented. CB has served as a consultant for NeuroPace, Advanced Bionics, Boston Scientific, IntelectMedical, Abbott (St. Jude Medical), Functional Neuromodulation, NeuraModix. JH served on the advisory board for Enspire DBS, a consultant for Neuralink and received research support from Boston Scientific. JH also received hardware support from Medtronic for the study described in this article. JJ has received research grants from the Michael J. Fox Foundation. DDD received research support and honoraria from Medtronic. HM received grant support from NIH UH3NS103550, 2R01MH102238, and the Hope for Depression Research Foundation, and consulting and licensing fees from Abbott Labs. PSh received research support from Medtronic but not financial support. MSO served as a consultant for the Parkinson’s Foundation, and has received research grants from NIH, Parkinson’s Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. MSO’s DBS research was supported by: NIH R01 NR014852 and R01NS096008. MSO was PI of the NIH R25NS108939 Training Grant.

Funding Information:
Traumatic Brain Injury (TBI) is a leading cause of long-term disability, due in large part to a lack of effective treatment options. Successful treatment of impaired mental processing speed and executive function could improve patient quality of life. Converging evidence from prior work in rodents, non-human primates and humans has provided evidence to support improving arousal and cognition through stimulation of central thalamus. We initiated a 6-participant feasibility study (CENTURY-S, NCT02881151, funded by NIH BRAIN Initiative grant UH3 NS095554) of central thalamic DBS (CT-DBS) in patients with moderate to severe TBI (msTBI). The trial was based on the hypothesis that activation of down-regulated frontostriatal systems would improve cognitive dysfunction, increase information processing speed and decrease fatiguability. We have reported our preliminary findings on CT-DBS in five participants to date with longstanding functional disability related to persistent cognitive dysfunction after severe TBI (age 23–60, 3–18 years after injury).

Publisher Copyright:
Copyright © 2022 Wong, Deuschl, Wolke, Bergman, Muthuraman, Groppa, Sheth, Bronte-Stewart, Wilkins, Petrucci, Lambert, Kehnemouyi, Starr, Little, Anso, Gilron, Poree, Kalamangalam, Worrell, Miller, Schiff, Butson, Henderson, Judy, Ramirez-Zamora, Foote, Silburn, Li, Oyama, Kamo, Sekimoto, Hattori, Giordano, DiEuliis, Shook, Doughtery, Widge, Mayberg, Cha, Choi, Heisig, Obatusin, Opri, Kaufman, Shirvalkar, Rozell, Alagapan, Raike, Bokil, Green and Okun.

Keywords

adaptive DBS
artificial intelligence
deep brain stimulation
epilepsy
interventional psychiatry
neuroethics
pain
traumatic brain injury

Publisher link

10.3389/fnhum.2022.813387

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury'. Together they form a unique fingerprint.

Cite this

Wong, J. K., Deuschl, G., Wolke, R., Bergman, H., Muthuraman, M., Groppa, S., Sheth, S. A., Bronte-Stewart, H. M., Wilkins, K. B., Petrucci, M. N., Lambert, E., Kehnemouyi, Y., Starr, P. A., Little, S., Anso, J., Gilron, R., Poree, L., Kalamangalam, G. P., Worrell, G. A., ... Okun, M. S. (2022). Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury. Frontiers in Human Neuroscience, 16, Article 813387. https://doi.org/10.3389/fnhum.2022.813387

Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury. / Wong, Joshua K.; Deuschl, Günther; Wolke, Robin et al.
In: Frontiers in Human Neuroscience, Vol. 16, 813387, 04.03.2022.

Research output: Contribution to journal › Article › peer-review

Wong, JK, Deuschl, G, Wolke, R, Bergman, H, Muthuraman, M, Groppa, S, Sheth, SA, Bronte-Stewart, HM, Wilkins, KB, Petrucci, MN, Lambert, E, Kehnemouyi, Y, Starr, PA, Little, S, Anso, J, Gilron, R, Poree, L, Kalamangalam, GP, Worrell, GA, Miller, KJ, Schiff, ND, Butson, CR, Henderson, JM, Judy, JW, Ramirez-Zamora, A, Foote, KD, Silburn, PA, Li, L, Oyama, G, Kamo, H, Sekimoto, S, Hattori, N, Giordano, JJ, DiEuliis, D, Shook, JR, Doughtery, DD, Widge, AS, Mayberg, HS, Cha, J, Choi, K, Heisig, S, Obatusin, M, Opri, E, Kaufman, SB, Shirvalkar, P, Rozell, CJ, Alagapan, S, Raike, RS, Bokil, H, Green, D & Okun, MS 2022, 'Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury', Frontiers in Human Neuroscience, vol. 16, 813387. https://doi.org/10.3389/fnhum.2022.813387

Wong JK, Deuschl G, Wolke R, Bergman H, Muthuraman M, Groppa S et al. Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury. Frontiers in Human Neuroscience. 2022 Mar 4;16:813387. doi: 10.3389/fnhum.2022.813387

@article{624473961fc14ed7b0b0d42d8490470b,

title = "Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury",

abstract = "DBS Think Tank IX was held on August 25–27, 2021 in Orlando FL with US based participants largely in person and overseas participants joining by video conferencing technology. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging deep brain stimulation (DBS) technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank IX speakers was that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. After collectively sharing our experiences, it was estimated that globally more than 230,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. As such, this year{\textquoteright}s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia and Australia; cutting-edge technologies, neuroethics, interventional psychiatry, adaptive DBS, neuromodulation for pain, network neuromodulation for epilepsy and neuromodulation for traumatic brain injury.",

keywords = "adaptive DBS, artificial intelligence, deep brain stimulation, epilepsy, interventional psychiatry, neuroethics, pain, traumatic brain injury",

author = "Wong, {Joshua K.} and G{\"u}nther Deuschl and Robin Wolke and Hagai Bergman and Muthuraman Muthuraman and Sergiu Groppa and Sheth, {Sameer A.} and Bronte-Stewart, {Helen M.} and Wilkins, {Kevin B.} and Petrucci, {Matthew N.} and Emilia Lambert and Yasmine Kehnemouyi and Starr, {Philip A.} and Simon Little and Juan Anso and Ro{\textquoteright}ee Gilron and Lawrence Poree and Kalamangalam, {Giridhar P.} and Worrell, {Gregory A.} and Miller, {Kai J.} and Schiff, {Nicholas D.} and Butson, {Christopher R.} and Henderson, {Jaimie M.} and Judy, {Jack W.} and Adolfo Ramirez-Zamora and Foote, {Kelly D.} and Silburn, {Peter A.} and Luming Li and Genko Oyama and Hikaru Kamo and Satoko Sekimoto and Nobutaka Hattori and Giordano, {James J.} and Diane DiEuliis and Shook, {John R.} and Doughtery, {Darin D.} and Widge, {Alik S.} and Mayberg, {Helen S.} and Jungho Cha and Kisueng Choi and Stephen Heisig and Mosadolu Obatusin and Enrico Opri and Kaufman, {Scott B.} and Prasad Shirvalkar and Rozell, {Christopher J.} and Sankaraleengam Alagapan and Raike, {Robert S.} and Hemant Bokil and David Green and Okun, {Michael S.}",

note = "Funding Information: JW{\textquoteright}s research was supported by NIH R25NS108939. SAS was a consultant for Boston Scientific, Abbott, Zimmer Biomet, and Neuropace. SAS was also funded by NIH UH3 NS103549, the McNair Foundation, and the Dana Foundation. HB-S served on the Clinical Advisory Board for Medtronic. PAS received research support and fellowship training support from Medtronic. NS was a member of the scientific advisory board for EnspireDBS, Inc. and QuantalX, Inc. NS also received current grant funding from the BRAIN Initiative, National Institute of Neurological Disorders and Stroke, and the James S. McDonnell Foundation. CB holds intellectual property related to some of the results presented. CB has served as a consultant for NeuroPace, Advanced Bionics, Boston Scientific, IntelectMedical, Abbott (St. Jude Medical), Functional Neuromodulation, NeuraModix. JH served on the advisory board for Enspire DBS, a consultant for Neuralink and received research support from Boston Scientific. JH also received hardware support from Medtronic for the study described in this article. JJ has received research grants from the Michael J. Fox Foundation. DDD received research support and honoraria from Medtronic. HM received grant support from NIH UH3NS103550, 2R01MH102238, and the Hope for Depression Research Foundation, and consulting and licensing fees from Abbott Labs. PSh received research support from Medtronic but not financial support. MSO served as a consultant for the Parkinson{\textquoteright}s Foundation, and has received research grants from NIH, Parkinson{\textquoteright}s Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. MSO{\textquoteright}s DBS research was supported by: NIH R01 NR014852 and R01NS096008. MSO was PI of the NIH R25NS108939 Training Grant. Funding Information: Traumatic Brain Injury (TBI) is a leading cause of long-term disability, due in large part to a lack of effective treatment options. Successful treatment of impaired mental processing speed and executive function could improve patient quality of life. Converging evidence from prior work in rodents, non-human primates and humans has provided evidence to support improving arousal and cognition through stimulation of central thalamus. We initiated a 6-participant feasibility study (CENTURY-S, NCT02881151, funded by NIH BRAIN Initiative grant UH3 NS095554) of central thalamic DBS (CT-DBS) in patients with moderate to severe TBI (msTBI). The trial was based on the hypothesis that activation of down-regulated frontostriatal systems would improve cognitive dysfunction, increase information processing speed and decrease fatiguability. We have reported our preliminary findings on CT-DBS in five participants to date with longstanding functional disability related to persistent cognitive dysfunction after severe TBI (age 23–60, 3–18 years after injury). Publisher Copyright: Copyright {\textcopyright} 2022 Wong, Deuschl, Wolke, Bergman, Muthuraman, Groppa, Sheth, Bronte-Stewart, Wilkins, Petrucci, Lambert, Kehnemouyi, Starr, Little, Anso, Gilron, Poree, Kalamangalam, Worrell, Miller, Schiff, Butson, Henderson, Judy, Ramirez-Zamora, Foote, Silburn, Li, Oyama, Kamo, Sekimoto, Hattori, Giordano, DiEuliis, Shook, Doughtery, Widge, Mayberg, Cha, Choi, Heisig, Obatusin, Opri, Kaufman, Shirvalkar, Rozell, Alagapan, Raike, Bokil, Green and Okun.",

year = "2022",

month = mar,

day = "4",

doi = "10.3389/fnhum.2022.813387",

language = "English (US)",

volume = "16",

journal = "Frontiers in Human Neuroscience",

issn = "1662-5161",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank

T2 - Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury

AU - Wong, Joshua K.

AU - Deuschl, Günther

AU - Wolke, Robin

AU - Bergman, Hagai

AU - Muthuraman, Muthuraman

AU - Groppa, Sergiu

AU - Sheth, Sameer A.

AU - Bronte-Stewart, Helen M.

AU - Wilkins, Kevin B.

AU - Petrucci, Matthew N.

AU - Lambert, Emilia

AU - Kehnemouyi, Yasmine

AU - Starr, Philip A.

AU - Little, Simon

AU - Anso, Juan

AU - Gilron, Ro’ee

AU - Poree, Lawrence

AU - Kalamangalam, Giridhar P.

AU - Worrell, Gregory A.

AU - Miller, Kai J.

AU - Schiff, Nicholas D.

AU - Butson, Christopher R.

AU - Henderson, Jaimie M.

AU - Judy, Jack W.

AU - Ramirez-Zamora, Adolfo

AU - Foote, Kelly D.

AU - Silburn, Peter A.

AU - Li, Luming

AU - Oyama, Genko

AU - Kamo, Hikaru

AU - Sekimoto, Satoko

AU - Hattori, Nobutaka

AU - Giordano, James J.

AU - DiEuliis, Diane

AU - Shook, John R.

AU - Doughtery, Darin D.

AU - Widge, Alik S.

AU - Mayberg, Helen S.

AU - Cha, Jungho

AU - Choi, Kisueng

AU - Heisig, Stephen

AU - Obatusin, Mosadolu

AU - Opri, Enrico

AU - Kaufman, Scott B.

AU - Shirvalkar, Prasad

AU - Rozell, Christopher J.

AU - Alagapan, Sankaraleengam

AU - Raike, Robert S.

AU - Bokil, Hemant

AU - Green, David

AU - Okun, Michael S.

N1 - Funding Information: JW’s research was supported by NIH R25NS108939. SAS was a consultant for Boston Scientific, Abbott, Zimmer Biomet, and Neuropace. SAS was also funded by NIH UH3 NS103549, the McNair Foundation, and the Dana Foundation. HB-S served on the Clinical Advisory Board for Medtronic. PAS received research support and fellowship training support from Medtronic. NS was a member of the scientific advisory board for EnspireDBS, Inc. and QuantalX, Inc. NS also received current grant funding from the BRAIN Initiative, National Institute of Neurological Disorders and Stroke, and the James S. McDonnell Foundation. CB holds intellectual property related to some of the results presented. CB has served as a consultant for NeuroPace, Advanced Bionics, Boston Scientific, IntelectMedical, Abbott (St. Jude Medical), Functional Neuromodulation, NeuraModix. JH served on the advisory board for Enspire DBS, a consultant for Neuralink and received research support from Boston Scientific. JH also received hardware support from Medtronic for the study described in this article. JJ has received research grants from the Michael J. Fox Foundation. DDD received research support and honoraria from Medtronic. HM received grant support from NIH UH3NS103550, 2R01MH102238, and the Hope for Depression Research Foundation, and consulting and licensing fees from Abbott Labs. PSh received research support from Medtronic but not financial support. MSO served as a consultant for the Parkinson’s Foundation, and has received research grants from NIH, Parkinson’s Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. MSO’s DBS research was supported by: NIH R01 NR014852 and R01NS096008. MSO was PI of the NIH R25NS108939 Training Grant. Funding Information: Traumatic Brain Injury (TBI) is a leading cause of long-term disability, due in large part to a lack of effective treatment options. Successful treatment of impaired mental processing speed and executive function could improve patient quality of life. Converging evidence from prior work in rodents, non-human primates and humans has provided evidence to support improving arousal and cognition through stimulation of central thalamus. We initiated a 6-participant feasibility study (CENTURY-S, NCT02881151, funded by NIH BRAIN Initiative grant UH3 NS095554) of central thalamic DBS (CT-DBS) in patients with moderate to severe TBI (msTBI). The trial was based on the hypothesis that activation of down-regulated frontostriatal systems would improve cognitive dysfunction, increase information processing speed and decrease fatiguability. We have reported our preliminary findings on CT-DBS in five participants to date with longstanding functional disability related to persistent cognitive dysfunction after severe TBI (age 23–60, 3–18 years after injury). Publisher Copyright: Copyright © 2022 Wong, Deuschl, Wolke, Bergman, Muthuraman, Groppa, Sheth, Bronte-Stewart, Wilkins, Petrucci, Lambert, Kehnemouyi, Starr, Little, Anso, Gilron, Poree, Kalamangalam, Worrell, Miller, Schiff, Butson, Henderson, Judy, Ramirez-Zamora, Foote, Silburn, Li, Oyama, Kamo, Sekimoto, Hattori, Giordano, DiEuliis, Shook, Doughtery, Widge, Mayberg, Cha, Choi, Heisig, Obatusin, Opri, Kaufman, Shirvalkar, Rozell, Alagapan, Raike, Bokil, Green and Okun.

PY - 2022/3/4

Y1 - 2022/3/4

N2 - DBS Think Tank IX was held on August 25–27, 2021 in Orlando FL with US based participants largely in person and overseas participants joining by video conferencing technology. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging deep brain stimulation (DBS) technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank IX speakers was that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. After collectively sharing our experiences, it was estimated that globally more than 230,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. As such, this year’s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia and Australia; cutting-edge technologies, neuroethics, interventional psychiatry, adaptive DBS, neuromodulation for pain, network neuromodulation for epilepsy and neuromodulation for traumatic brain injury.

AB - DBS Think Tank IX was held on August 25–27, 2021 in Orlando FL with US based participants largely in person and overseas participants joining by video conferencing technology. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging deep brain stimulation (DBS) technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank IX speakers was that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. After collectively sharing our experiences, it was estimated that globally more than 230,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. As such, this year’s meeting was focused on advances in the following areas: neuromodulation in Europe, Asia and Australia; cutting-edge technologies, neuroethics, interventional psychiatry, adaptive DBS, neuromodulation for pain, network neuromodulation for epilepsy and neuromodulation for traumatic brain injury.

KW - adaptive DBS

KW - artificial intelligence

KW - deep brain stimulation

KW - epilepsy

KW - interventional psychiatry

KW - neuroethics

KW - pain

KW - traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=85127364662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127364662&partnerID=8YFLogxK

U2 - 10.3389/fnhum.2022.813387

DO - 10.3389/fnhum.2022.813387

M3 - Article

C2 - 35308605

AN - SCOPUS:85127364662

SN - 1662-5161

VL - 16

JO - Frontiers in Human Neuroscience

JF - Frontiers in Human Neuroscience

M1 - 813387

ER -

Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this